Health committee  I do not want to monopolize the discussion, but I can give you a few opinions on the matter. I would also like to add a few details regarding the previous question, namely the success of nanotechnologies. To date, we have promised a lot of benefits to consumers. True, when it co

Health committee  Yes, but I might disappoint you. Indeed, as far as the American system is concerned, I cannot tell you very much, because my comparative analysis really focused on the European Union and Canada. However, I am going to be working on the third aspect, no doubt starting in September

Health committee  As for the impact of nanoparticles on health and the environment, given the number of studies that have been done, there is a scientific consensus that has existed for quite some yearsnow—perhaps Mr. Emond could confirm this—on the toxicity of certain nanoparticles, both for heal

Health committee  In Canada, we know that Bill C-6 was unfortunately withdrawn. We hope that the bill will soon be revived so that Canada may have a legislative framework comparable to that of the European Union. I now come to the issue of convergence. I would simply like to point out the areas o

Health committee  Good morning and thank you for your invitation. I hope that I will manage to speak slowly because one does have to move quickly when one only has five minutes. I'll start by introducing myself. Currently I am working under the direction of Louise Vandelac, at UQAM, in a team tha